Effect of Genetic Variation in CYP450 on Gonadal Impairment in a European Cohort of Female Childhood Cancer Survivors, Based on a Candidate Gene Approach: Results from the PanCareLIFE Study
暂无分享,去创建一个
A. Uitterlinden | S. Fosså | U. Dirksen | M. Hudson | L. Robison | L. Broer | F. V. van Leeuwen | C. Lambalk | R. V. van Schaik | J. Laven | J. N. van den Anker | E. van Dulmen-den Broeder | C. Spix | J. Byrne | D. Modan-Moses | Y. Yasui | G. Kaspers | W. Tissing | L. Kremer | M. V. D. van den Heuvel-Eibrink | R. Brooke | D. Grabow | P. Kaatsch | C. Beerendonk | H. V. D. van der Pal | O. Zolk | M. Muraca | A. de Vries | B. Versluys | T. Kepak | J. Kruseová | M. Kaiser | C. Berger | J. Loonen | D. Bresters | A. Bos | A. Overbeek | E. Clemens | A. V. D. van der Kooi | M. V. D. van der Perk | Jessica L Baedke | Jeanette Falck Winther | J. Krijthe | J. Baedke | On Behalf Of The PanCareLIFE Consortium | A. Uitterlinden | A. D. de Vries | T. Kepák | M. M. van der Perk | J. Falck Winther | Jessica L. Baedke